| GA23255-005mg |
|
131448-51-6 |
Neuropeptide Y (1-24) amide (human, rat)
|
0 |
C116H170N30O40S |
|
|
|
| GA23254-1mg |
|
383415-90-5 |
|
0 |
C165H249N49O38S |
|
|
|
| GA23254-005mg |
|
383415-90-5 |
|
0 |
C165H249N49O38S |
|
|
|
| GA23253-1mg |
|
96827-05-3 |
Neuropeptide K (human, porcine, rat)
|
0 |
C175H284N52O52S |
|
|
|
| GA23253-005mg |
|
96827-05-3 |
Neuropeptide K (human, porcine, rat)
|
0 |
C175H284N52O52S |
|
|
|
| GA23252-1mg |
|
134748-04-2 |
|
0 |
C81H125N23O34 |
|
|
|
| GA23252-005mg |
|
134748-04-2 |
|
0 |
C81H125N23O34 |
|
|
|
| GA23251-1mg |
|
1872435-06-7 |
Neuronostatin-19 (human, canine, porcine)
|
0 |
C90H151N29O25 |
|
|
|
| GA23251-005mg |
|
1872435-06-7 |
Neuronostatin-19 (human, canine, porcine)
|
0 |
C90H151N29O25 |
|
|
|
| GA23250-1mg |
|
1872435-05-6 |
Neuronostatin-13 (mouse, rat)
|
0 |
C65H112N20O17 |
|
|
|
| GA23250-005mg |
|
1872435-05-6 |
Neuronostatin-13 (mouse, rat)
|
0 |
C65H112N20O17 |
|
|
|
| GA23249-5mg |
|
98395-75-6 |
|
0 |
C54H78N16O10 |
|
|
|
| GA23249-1mg |
|
98395-75-6 |
|
0 |
C54H78N16O10 |
|
|
|
| GA23248-1mg |
|
98395-76-7 |
Neuromedin U-25 (porcine)
|
0 |
C144H217N43O37 |
|
|
|
| GA23248-005mg |
|
98395-76-7 |
Neuromedin U-25 (porcine)
|
0 |
C144H217N43O37 |
|
|
|
| GA23247-1mg |
|
1872441-24-1 |
Neuroendocrine Regulatory Peptide-2 (rat)
|
0 |
C175H290N56O59 |
|
|
|
| GA23247-005mg |
|
1872441-24-1 |
Neuroendocrine Regulatory Peptide-2 (rat)
|
0 |
C175H290N56O59 |
|
|
|
| GA23246-1mg |
|
954420-51-0 |
Neuroendocrine Regulatory Peptide-1 (rat)
|
0 |
C110H180N32O38 |
|
|
|
| GA23246-005mg |
|
954420-51-0 |
Neuroendocrine Regulatory Peptide-1 (rat)
|
0 |
C110H180N32O38 |
|
|
|
| GA23245-250mg |
|
282726-22-1 |
|
0 |
C19H31N3O2 |
|
|
|
